493 related articles for article (PubMed ID: 31529195)
1. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.
Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB
J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195
[TBL] [Abstract][Full Text] [Related]
2. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro.
Tanaka T; Ikegami Y; Nakazawa H; Kuriyama N; Oki M; Hanai J; Sukhatme VP; Kaneki M
J Cell Physiol; 2017 Jan; 232(1):192-201. PubMed ID: 27137755
[TBL] [Abstract][Full Text] [Related]
4. Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy.
Liu Q; Guan C; Liu C; Li H; Wu J; Sun C
Biomed Pharmacother; 2022 Dec; 156():113861. PubMed ID: 36228375
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia Inducible Factors Modify Collagen I Fibers in MDA-MB-231 Triple Negative Breast Cancer Xenografts.
Goggins E; Kakkad S; Mironchik Y; Jacob D; Wildes F; Krishnamachary B; Bhujwalla ZM
Neoplasia; 2018 Feb; 20(2):131-139. PubMed ID: 29247885
[TBL] [Abstract][Full Text] [Related]
6. EMMPRIN Down-regulating miR-106a/b Modifies Breast Cancer Stem-like Cell Properties via Interaction with Fibroblasts Through STAT3 and HIF-1α.
Liu Y; Zhang J; Sun X; Li M
Sci Rep; 2016 Jun; 6():28329. PubMed ID: 27325313
[TBL] [Abstract][Full Text] [Related]
7. Sanguinarine disrupts the colocalization and interaction of HIF-1α with tyrosine and serine phosphorylated-STAT3 in breast cancer.
Su Q; Wang J; Fan M; Ghauri MA; Ullah A; Wang B; Dai B; Zhan Y; Zhang D; Zhang Y
J Cell Mol Med; 2020 Mar; 24(6):3756-3761. PubMed ID: 32065498
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy.
Broad RV; Jones SJ; Teske MC; Wastall LM; Hanby AM; Thorne JL; Hughes TA
Br J Cancer; 2021 Mar; 124(6):1110-1120. PubMed ID: 33398063
[TBL] [Abstract][Full Text] [Related]
9. Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.
Yehia L; Boulos F; Jabbour M; Mahfoud Z; Fakhruddin N; El-Sabban M
PLoS One; 2015; 10(6):e0129356. PubMed ID: 26046764
[TBL] [Abstract][Full Text] [Related]
10. Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.
Alraouji NN; Al-Mohanna FH; Ghebeh H; Arafah M; Almeer R; Al-Tweigeri T; Aboussekhra A
Mol Carcinog; 2020 Sep; 59(9):1041-1051. PubMed ID: 32537818
[TBL] [Abstract][Full Text] [Related]
11. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA (lncRNA) metallothionein 1 J, pseudogene (MT1JP) is downregulated in triple-negative breast cancer and upregulates microRNA-138 (miR-138) to downregulate hypoxia-inducible factor-1α (HIF-1α).
Wang G; Dong Y; Liu H; Ji N; Cao J; Liu A; Tang X; Ren Y
Bioengineered; 2022 May; 13(5):13718-13727. PubMed ID: 35703312
[TBL] [Abstract][Full Text] [Related]
13. Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer.
Li S; Wei Q; Li Q; Zhang B; Xiao Q
Cancer Biol Ther; 2015; 16(6):866-75. PubMed ID: 25920936
[TBL] [Abstract][Full Text] [Related]
14. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 contributes to chemoresistance in MDA-MB-231 cells via targeting HIF-1α.
Wang K; Zhu X; Zhang K; Yin Y; Chen Y; Zhang T
J Biochem Mol Toxicol; 2018 Mar; 32(3):e22039. PubMed ID: 29341321
[TBL] [Abstract][Full Text] [Related]
16. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
17. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
Ring A; Kaur P; Lang JE
BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
[TBL] [Abstract][Full Text] [Related]
18. Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells
Cecil DL; Slota M; O'Meara MM; Curtis BC; Gad E; Dang Y; Herendeen D; Rastetter L; Disis ML
Clin Cancer Res; 2017 Jul; 23(13):3396-3404. PubMed ID: 28039264
[No Abstract] [Full Text] [Related]
19. The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer.
Chen M; Liu Z; Zheng K; Hu C; Peng P
Medicine (Baltimore); 2024 Jun; 103(23):e38434. PubMed ID: 38847725
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy-Resistant Breast Cancer Cells Enhance Tumor Progression by Enhancing Premetastatic Niche Formation through the HIF-1α-LOX Axis.
Ko YS; Rugira T; Jin H; Joo YN; Kim HJ
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]